Skip to content

Clinical trials

Phase 1 Leukemia, Promyelocytic, Acute trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Promyelocytic, Acute Phase: Phase 1 Country / region: Canada Clear all

2 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid, Acute2
Leukemia, Myelomonocytic, Chronic2
Leukemia, Promyelocytic, Acute2
Myeloproliferative Disorders2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Primary Myelofibrosis2
Recurrence2
Blast Crisis1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1

Trials

Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.